Teva: O'Grady senior vice president and CEO of the North American Commercial Division

Teva announced a round of appointments following the retirement of one of the company's key members: Brendan O'Grady, senior vice president and CEO of the North American Commercial Division, which is Teva's largest market.
Augrade, the most experienced manager at Teva, informed CEO Kor Schultz of his decision to leave his position at Teva after 30 years of working for the company in favor of working outside the pharmaceutical industry.
O'Grady will be replaced by the Director General of the North American Commercial Division, Dr. Sven Detleps, Senior Vice President and Director of the Global Marketing and Portfolio Division and the Director General of the Commercial Division in International Markets.
Following the round of appointments, four Israelis will now serve in Teva's senior management and six senior management members will operate in Israel, as part of CEO Kor Schultz's policy and as an expression of Teva's commitment to Israel, following investment in strategic R&D and strategic collaborations with Israeli academia. As part of the changes, another Israeli woman was photographed for Teva's senior management.
Mark Sabag, Director of Human Resources, Global Communications and Brand and ESG in Teva, will be appointed CEO of the Commercial Division in International Markets. "Global Human Resources, will replace Sabag. Inbar, in her current senior position, defined Teva's strategy in the development of Teva's human resources, including during the Corona plague.
Eli Shani will be appointed Senior Vice President, Head of the Global Marketing and Portfolio Division.